Does testosterone therapy improve skin in men?

Testosterone therapy in men with confirmed hypogonadism (total testosterone consistently below 300 ng/dL) produces measurable improvements in skin thickness, collagen density, sebaceous gland activity (increased skin oil), and wound healing speed, driven by androgen receptor activation in dermal fibroblasts and keratinocytes, but these effects are secondary outcomes in TRT trials, not primary indications for therapy (Brincat, Maturitas, 200000085-8)).

This is not an argument for pursuing testosterone therapy for skin reasons. The primary indication for TRT is symptomatic hypogonadism confirmed by laboratory testing, with cardiovascular pre-screening performed by a cardiologist or internist. Skin improvement, when it occurs, is a secondary benefit. Men pursuing TRT specifically for skin improvement are prioritizing a secondary outcome over a primary cardiovascular safety evaluation. The more relevant point is that optimizing testosterone through lifestyle (exercise, sleep restoration, visceral fat reduction, cortisol management) produces equivalent or near-equivalent skin benefits without the risks associated with exogenous testosterone.

Honesty Scale: Promising (2) for TRT improving skin thickness in hypogonadal men. Solid (1) for the primary indication and safety requirements.

What to do: Address skin health through the lifestyle interventions that simultaneously optimize testosterone: resistance training, adequate sleep, visceral fat reduction, and stress management. If you also have symptomatic hypogonadism, pursue a proper TRT evaluation with a physician who performs cardiovascular pre-screening.

For the full picture, read The Skin Health Deep Dive